Live feed11:39:00·6mPRReleasevia QuantisnowMore than 75% of Leqembi®-treated patients remained stable and nearly 7% improved over an average of 17 months of treatment in real-world LEADER study data presented at AAIC® 2026ByQuantisnow·Wall Street's wire, on your screen.BIOA· BioAge Labs Inc.Health Care
